Author

F. K. Deshryver

Institutions: Good Samaritan Hospital, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Doctors Hospital of Laredo, Duke Medical Center

Observed institutions: Good Samaritan Hospital, Mayo Clinic, The University of Texas MD Anderson Cancer Center, Doctors Hospital of Laredo, Duke Medical Center

OpenAlex ID: A5063333233

ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer.

2010 · M. J. Ellis, G. Babiera, et al. · Journal of Clinical Oncology · 22

Works count: 1

Citation count: 22

H-index: 1

I10-index: 1